Requires Adobe Acrobat ReaderRequires Adobe Acrobat ReaderData Tables
| View HTML | View PDF | |
|---|---|---|
Section I | ||
| 1.1 | U.S. Organ Donors by Organ and Donor Type, 1999 to 2008 | (27 k) |
| 1.2 | Number of Organs Recovered from Deceased Donors, 1999 to 2008 | (24 k) |
| 1.3 | Waiting List at End of Year, 1999 to 2008 | (27 k) |
| 1.4 | Characteristics of Waiting List Patients at End of Year, 1999 to 2008 | (38 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Patient Status | ||
| 1.5 | Time to Transplant New Waiting List Registrations, 1999 to 2008 | (41 k) |
| 1.6 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk Waiting List, 1999 to 2008 | (29 k) |
| 1.7 | Transplants by Organ and Donor Type, 1999 to 2008 | (32 k) |
| 1.8 | Multi-Organ Transplants, 1999 to 2008 | (25 k) |
| 1.9a | Immunosuppression Use by Organ in 2007 and 2008 | (38 k) |
| 1.9b | Immunosuppression Use by Organ Maintenance Regimen at Discharge, 2008 Transplants | (30 k) |
| 1.9c | Immunosuppression Use by Organ Maintenance Regimen at One Year Following Transplantation 2007 Transplants | (30 k) |
| 1.10 | Transplant Recipient Characteristics, 1999 to 2008 | (37 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 1.11a | One Year Adjusted Graft Survival by Organ and Year of Transplant, 1998 to 2007 | (30 k) |
| 1.11b | One Year Unadjusted Graft Survival by Organ and Year of Transplant, 1998 to 2007 | (30 k) |
| 1.12a | One Year Adjusted Patient Survival by Organ and Year of Transplant, 1998 to 2007 | (30 k) |
| 1.12b | One Year Unadjusted Patient Survival by Organ and Year of Transplant, 1998 to 2007 | (30 k) |
| 1.13 | Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years Standard Errors of the Survival Rates | (37 k) |
| Standard Errors of the Survival Rates | ||
| Survival (%) | ||
| Number of Transplants For This Survival Analysis | ||
| 1.14 | Prevalence of People Living with a Functioning Transplant at End of Year 1999 to 2007 | (20 k) |
Section II | ||
| 2.1 | Deceased Donor Characteristics, 1999 to 2008 Deceased Donors of Any Organ | (46 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Donation After Cardiac Death | ||
| Race | ||
| 2.2 | Deceased Donor Characteristics, 1999 to 2008 Kidney Donors | (48 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Race | ||
| Donor Category(ECD, SCD, DCD) | ||
| 2.3 | Deceased Donor Characteristics, 1999 to 2008 Pancreas Donors | (46 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Donation After Cardiac Death | ||
| Race | ||
| 2.4 | Deceased Donor Characteristics, 1999 to 2008 Liver Donors | (46 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Donation After Cardiac Death | ||
| Race | ||
| 2.5 | Deceased Donor Characteristics, 1999 to 2008 Intestine Donors | (45 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Donation After Cardiac Death | ||
| Race | ||
| 2.6 | Deceased Donor Characteristics, 1999 to 2008 Heart Donors | (45 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Race | ||
| 2.7 | Deceased Donor Characteristics, 1999 to 2008 Lung Donors | (46 k) |
| Age | ||
| Blood Type | ||
| Cause of Death | ||
| Circumstance of Death | ||
| Mechanism of Death | ||
| Gender | ||
| Donation After Cardiac Death | ||
| Race | ||
| 2.8 | Living Donor Characteristics, 1999 to 2008 Living Donors of Any Organ | (40 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Donor Hospitalization | ||
| Race | ||
| Donor Relation | ||
| Donor Status | ||
| 2.9 | Living Donor Characteristics, 1999 to 2008 Kidney Donors | (40 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Donor Hospitalization | ||
| Race | ||
| Donor Relation | ||
| Donor Status | ||
| 2.10 | Living Donor Characteristics, 1999 to 2008 Liver Segment Donors | (39 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Donor Hospitalization | ||
| Race | ||
| Donor Relation | ||
| Donor Status | ||
| 2.11 | Living Donor Characteristics, 1999 to 2008 Lung Lobe Donors | (38 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Donor Hospitalization | ||
| Race | ||
| Donor Relation | ||
| Donor Status | ||
| 2.12 | Deceased Donor Organ Utilization, 1999 to 2008, Any Organ | (35 k) |
| 2.13 | Deceased Donor Organ Utilization, 1999 to 2008, Kidney | (42 k) |
| 2.14 | Deceased Donor Organ Utilization, 1999 to 2008, Pancreas | (41 k) |
| 2.15 | Deceased Donor Organ Utilization, 1999 to 2008, Liver | (44 k) |
| 2.16 | Deceased Donor Organ Utilization, 1999 to 2008, Intestine | (37 k) |
| 2.17 | Deceased Donor Organ Utilization, 1999 to 2008, Heart | (39 k) |
| 2.18 | Deceased Donor Organ Utilization, 1999 to 2008, Lung | (40 k) |
Section III | ||
| 3.1 | Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 Kidney | (26 k) |
| 3.2 | Reasons for Non-Use of Recovered Organs, 1999 to 2008 Kidney | (29 k) |
| 3.3 | Reasons for Non-Recovery of Consented Organs, 1999 to 2008 Kidney | (28 k) |
| 3.4 | Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 Pancreas | (25 k) |
| 3.5 | Reasons for Non-Use of Recovered Organs, 1999 to 2008 Pancreas | (29 k) |
| 3.6 | Reasons for Non-Recovery of Consented Organs, 1999 to 2008 Pancreas | (28 k) |
| 3.7 | Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 Liver | (27 k) |
| 3.8 | Reasons for Non-Use of Recovered Organs, 1999 to 2008 Liver | (29 k) |
| 3.9 | Reasons for Non-Recovery of Consented Organs, 1999 to 2008 Liver | (28 k) |
| 3.10 | Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 Intestine | (26 k) |
| 3.11 | Reasons for Non-Use of Recovered Organs, 1999 to 2008 Intestine | (33 k) |
| 3.12 | Reasons for Non-Recovery of Consented Organs, 1999 to 2008 Intestine | (28 k) |
| 3.13 | Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 Heart | (26 k) |
| 3.14 | Reasons for Non-Use of Recovered Organs, 1999 to 2008 Heart | (29 k) |
| 3.15 | Reasons for Non-Recovery of Consented Organs, 1999 to 2008 Heart | (28 k) |
| 3.16 | Disposition of Organs Recovered from Deceased Donors, 1999 to 2008 Lung | (26 k) |
| 3.17 | Reasons for Non-Use of Recovered Organs, 1999 to 2008 Lung | (29 k) |
| 3.18 | Reasons for Non-Recovery of Consented Organs, 1999 to 2008 Lung | (28 k) |
Section IV | ||
| 4.1 | Deceased Donors Procured by U.S. Organ Procurement Organizations 1999 to 2008 | (50 k) |
| 4.2 | Eligible Deaths Reported by U.S. Organ Procurement Organizations 2001 to 2008 | (49 k) |
| 4.3 | Transplant Centers Within Each OPO CMS-Designated Service Area As of May 2009, By Home State of OPO | (75 k) |
Section V | ||
| 5.1a | Waiting List Patient Characteristics at End of Year Kidney Waiting List Active Waitlist Patients, 1999 to 2008 | (46 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 5.1b | Waiting List Patient Characteristics at End of Year Kidney Waiting List Inactive Waitlist Patients, 1999 to 2008 | (46 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 5.2 | Time to Transplant, 1999 to 2008 New Kidney Waiting List Registrations | (158 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| PRA | ||
| Gender and PRA | ||
| Race and PRA | ||
| Previous Transplant Any Organ | ||
| Previous Transplant and Gender | ||
| Previous Transplant and PRA | ||
| Previous Transplant and Race | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 5.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Kidney Waiting List | (83 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 5.4 | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor Kidneys | (30 k) |
| 5.4a | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor non-ECD Kidneys | (67 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 5.4b | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor Expanded Criteria Donors (ECD) Kidneys | (67 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 5.4c | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor Kidneys | (67 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 5.4d | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Living Donor Kidneys | (66 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Relation | ||
| Diagnosis | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 5.5 | Incidence of Transplant, 1999 to 2008 Kidney Transplants per 1 Million Population | (53 k) |
| 5.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Kidney Transplants | (32 k) |
| 5.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Kidney Transplants | (32 k) |
| 5.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Kidney Transplants | (30 k) |
| 5.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Kidney Transplants | (29 k) |
| 5.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Kidney Transplants | (33 k) |
| 5.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Kidney Transplants | (30 k) |
| 5.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Kidney Transplants | (33 k) |
| 5.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Kidney Transplants | (48 k) |
| 5.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Kidney Transplants | (32 k) |
| 5.7a | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor non-ECD Kidney Transplantation | (156 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| Diagnosis | ||
| State of Center | ||
| 5.7b | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor ECD Kidney Transplantation | (142 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| Diagnosis | ||
| State of Center | ||
| 5.7c | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Kidney Transplantation | (172 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| Diagnosis | ||
| State of Center | ||
| 5.7d | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Living Donor Kidney Transplantation | (129 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| Diagnosis | ||
| State of Center | ||
| 5.8a | Adjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (50 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.8b | Adjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (49 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.8c | Adjusted Graft Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (49 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.8d | Adjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (48 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.9a | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants | (22 k) |
| 5.9b | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants | (22 k) |
| 5.9c | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants | (22 k) |
| 5.9d | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants | (22 k) |
| 5.10a | Unadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (64 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.10b | Unadjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (60 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.10c | Unadjusted Graft Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (64 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.10d | Unadjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (66 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Relation | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.11a | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants | (22 k) |
| 5.11b | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants | (22 k) |
| 5.11c | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants | (22 k) |
| 5.11d | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants | (22 k) |
| 5.12a | Adjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (50 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.12b | Adjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (49 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.12c | Adjusted Patient Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (50 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.12d | Adjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (48 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 5.13a | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants | (22 k) |
| 5.13b | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants | (22 k) |
| 5.13c | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants | (22 k) |
| 5.13d | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants | (22 k) |
| 5.14a | Unadjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (63 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.14b | Unadjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (60 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.14c | Unadjusted Patient Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (64 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.14d | Unadjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (65 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Relation | ||
| Donor Age | ||
| Diagnosis | ||
| Dialysis Within 1 Week of Tx | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 5.15a | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants | (22 k) |
| 5.15b | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants | (22 k) |
| 5.15c | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants | (22 k) |
| 5.15d | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants | (22 k) |
| 5.16 | Prevalence of People Living with a Functioning Transplant at End of Year Kidney Recipients, 1999 to 2007 | (58 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Type | ||
| Age | ||
| Diagnosis | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 5.17 | Transplants by State and Transplant Center, 1999 to 2008 Kidney | (98 k) |
Section VI | ||
| 6.1a | Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1999 to 2008 | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 6.1b | Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Inactive Waitlist Patients, 1999 to 2008 | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 6.2 | Time to Transplant, 1999 to 2008 New Pancreas Transplant Alone (PTA) Waiting List Registrations | (93 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 6.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Pancreas Transplant Alone (PTA) Waiting List | (65 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 6.4 | Transplant Recipient Characteristics, 1999 to 2008 Pancreas Transplant Alone (PTA) Recipients | (41 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 6.5 | Incidence of Transplant, 1999 to 2008 Pancreas Transplant Alone (PTA) Transplants per 1 Million Population | (47 k) |
| 6.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) Transplants | (32 k) |
| 6.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Pancreas Transplant Alone (PTA) Transplants | (32 k) |
| 6.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Pancreas Transplant Alone (PTA) Transplants | (29 k) |
| 6.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) Transplants | (29 k) |
| 6.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) Transplants | (29 k) |
| 6.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 6.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 6.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants | (46 k) |
| 6.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 6.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) Transplantation | (99 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 6.8 | Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (37 k) |
| Age | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 6.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.10 | Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (48 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 6.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.12 | Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (37 k) |
| Age | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 6.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.14 | Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (47 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 6.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.16 | Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1999 to 2007 | (38 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 6.17 | Transplants by State and Transplant Center, 1999 to 2008 Pancreas Transplant Alone (PTA) | (64 k) |
Section VII | ||
| 7.1a | Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1999 to 2008 | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 7.1b | Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Inactive Waitlist Patients, 1999 to 2008 | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 7.2 | Time to Transplant, 1999 to 2008 New Pancreas After Kidney (PAK) Waiting List Registrations | (93 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 7.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Pancreas After Kidney (PAK) Waiting List | (70 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 7.4 | Transplant Recipient Characteristics, 1999 to 2008 Pancreas After Kidney (PAK) Recipients | (41 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Payment Source | ||
| 7.5 | Incidence of Transplant, 1999 to 2008 Pancreas After Kidney (PAK) Transplants per 1 Million Population | (48 k) |
| 7.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Pancreas After Kidney (PAK) Transplants | (32 k) |
| 7.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Pancreas After Kidney (PAK) Transplants | (32 k) |
| 7.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Pancreas After Kidney (PAK) Transplants | (29 k) |
| 7.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Pancreas After Kidney (PAK) Transplants | (29 k) |
| 7.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Pancreas After Kidney (PAK) Transplants | (30 k) |
| 7.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants | (30 k) |
| 7.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants | (33 k) |
| 7.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants | (48 k) |
| 7.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants | (32 k) |
| 7.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Pancreas After Kidney (PAK) Transplantation | (106 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 7.8 | Adjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (42 k) |
| Age | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 7.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants | (22 k) |
| 7.10 | Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (52 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 7.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants | (22 k) |
| 7.12 | Adjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (42 k) |
| Age | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 7.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants | (22 k) |
| 7.14 | Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (51 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 7.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants | (22 k) |
| 7.16 | Prevalence of People Living with a Functioning Transplant at End of Year Pancreas After Kidney (PAK) Recipients, 1999 to 2007 | (37 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| 7.17 | Transplants by State and Transplant Center, 1999 to 2008 Pancreas After Kidney (PAK) | (79 k) |
Section VIII | ||
| 8.1a | Waiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Active Waitlist Patients, 1999 to 2008 | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 8.1b | Waiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Inactive Waitlist Patients, 1999 to 2008 | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 8.2 | Time to Transplant, 1999 to 2008 New Kidney-Pancreas Waiting List Registrations | (110 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 8.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Kidney-Pancreas Waiting List | (70 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 8.4 | Transplant Recipient Characteristics, 1999 to 2008 Kidney-Pancreas Recipients | (58 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 8.5 | Incidence of Transplant, 1999 to 2008 Kidney-Pancreas Transplants per 1 Million Population | (48 k) |
| 8.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Kidney-Pancreas Transplants | (32 k) |
| 8.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Kidney-Pancreas Transplants | (32 k) |
| 8.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Kidney-Pancreas Transplants | (29 k) |
| 8.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Kidney-Pancreas Transplants | (29 k) |
| 8.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Kidney-Pancreas Transplants | (30 k) |
| 8.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Kidney-Pancreas Transplants | (30 k) |
| 8.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Kidney-Pancreas Transplants | (33 k) |
| 8.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Kidney-Pancreas Transplants | (37 k) |
| 8.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Kidney-Pancreas Transplants | (31 k) |
| 8.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Kidney-Pancreas Transplantation | (125 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| Previous Kidney Transplant | ||
| Previous Pancreas Transplant | ||
| State of Center | ||
| 8.8 | Adjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (55 k) |
| Kidney Graft - by Age | ||
| Pancreas Graft - by Age | ||
| Kidney Graft - by Gender | ||
| Pancreas Graft - by Gender | ||
| Kidney Graft - by Race | ||
| Pancreas Graft - by Race | ||
| Kidney Graft - by State of Center | ||
| Pancreas Graft - by State of Center | ||
| 8.9a | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney Graft | (22 k) |
| 8.9b | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas Graft | (22 k) |
| 8.10 | Unadjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (84 k) |
| Kidney Graft - by Age | ||
| Pancreas Graft - by Age | ||
| Kidney Graft - by Blood Type | ||
| Pancreas Graft - by Blood Type | ||
| Kidney Graft - by Residency | ||
| Pancreas Graft - by Residency | ||
| Kidney Graft - by Gender | ||
| Pancreas Graft - by Gender | ||
| Kidney Graft - by PRA | ||
| Pancreas Graft - by PRA | ||
| Kidney Graft - by Race | ||
| Pancreas Graft - by Race | ||
| Kidney Graft - by Center Volume | ||
| Pancreas Graft - by Center Volume | ||
| Kidney Graft - by Donor Age | ||
| Pancreas Graft - by Donor Age | ||
| Previous Transplant Same Organ Kidney Graft | ||
| Previous Transplant Same Organ Pancreas Graft | ||
| Kidney Graft - by Cold Ischemic Time | ||
| Kidney Graft - by Hospitalized at Tx | ||
| Pancreas Graft - by Hospitalized at Tx | ||
| Kidney Graft - by Level of HLA Mismatch | ||
| Pancreas Graft - by Level of HLA Mismatch | ||
| Kidney Graft - by Previous Kidney Transplant | ||
| Pancreas Graft - by Previous Kidney Transplant | ||
| Kidney Graft - by Previous Pancreas Transplant | ||
| Pancreas Graft - by Previous Pancreas Transplant | ||
| Kidney Graft - by State of Center | ||
| Pancreas Graft - by State of Center | ||
| 8.11a | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney Graft | (22 k) |
| 8.11b | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas Graft | (22 k) |
| 8.12 | Adjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (42 k) |
| Age | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 8.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years | (22 k) |
| 8.14 | Unadjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (56 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| PRA | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| State of Center | ||
| 8.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years | (22 k) |
| 8.16 | Prevalence of People Living with a Functioning Transplant at End of Year Kidney-Pancreas Recipients, 1999 to 2007 | (46 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| PRA | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 8.17 | Transplants by State and Transplant Center, 1999 to 2008 Kidney-Pancreas | (71 k) |
Section IX | ||
| 9.1a | Waiting List Patient Characteristics at End of Year Liver Waiting List Active Waitlist Patients, 1999 to 2008 | (53 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Patient Status | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 9.1b | Waiting List Patient Characteristics at End of Year Liver Waiting List Inactive Waitlist Patients, 1999 to 2008 | (44 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 9.2a | Events 7 & 15 Days After Listing 2007 and 2008 Liver Registrations with Initial Status 1 | (21 k) |
| 9.2b | Events 30 Days After Snapshot of Prevalent Waiting List Adult Patients on Liver Waiting List on Jan. 1, 2008 | (38 k) |
| 30 Days After Snapshot | ||
| 60 Days After Snapshot | ||
| 90 Days After Snapshot | ||
| 9.2c | Events 30 Days After Snapshot of Prevalent Waiting List Pediatric Patients on Liver Waiting List on Jan. 1, 2008 | (36 k) |
| 30 Days After Snapshot | ||
| 60 Days After Snapshot | ||
| 90 Days After Snapshot | ||
| 9.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Liver Waiting List | (88 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| Patient Status | ||
| State of Center | ||
| 9.4a | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor Livers | (53 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| Procedure Type | ||
| 9.4b | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Living Donor Livers | (52 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Donor Relation | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 9.5 | Incidence of Transplant, 1999 to 2008 Liver Transplants per 1 Million Population | (48 k) |
| 9.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Liver Transplants | (32 k) |
| 9.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Liver Transplants | (32 k) |
| 9.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Liver Transplants | (29 k) |
| 9.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Liver Transplants | (29 k) |
| 9.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Liver Transplants | (33 k) |
| 9.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Liver Transplants | (30 k) |
| 9.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Liver Transplants | (33 k) |
| 9.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Liver Transplants | (37 k) |
| 9.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Liver Transplants | (32 k) |
| 9.7a | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Liver Transplantation | (126 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 9.7b | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Living Donor Liver Transplantation | (105 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 9.8a | Adjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (49 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 9.8b | Adjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (42 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 9.9a | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants | (22 k) |
| 9.9b | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants | (22 k) |
| 9.10a | Unadjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (60 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 9.10b | Unadjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (54 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Center Volume | ||
| Donor Relation | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 9.11a | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants | (22 k) |
| 9.11b | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants | (22 k) |
| 9.12a | Adjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (49 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 9.12b | Adjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (42 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 9.13a | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants | (22 k) |
| 9.13b | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants | (22 k) |
| 9.14a | Unadjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (60 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 9.14b | Unadjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (54 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Center Volume | ||
| Donor Relation | ||
| Donor Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 9.15a | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants | (22 k) |
| 9.15b | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants | (22 k) |
| 9.16 | Prevalence of People Living with a Functioning Transplant at End of Year Liver Recipients, 1999 to 2007 | (54 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Donor Type | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 9.17 | Transplants by State and Transplant Center, 1999 to 2008 Liver | (70 k) |
Section X | ||
| 10.1a | Waiting List Patient Characteristics at End of Year Intestine Waiting List Active Waitlist Patients, 1999 to 2008 | (43 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 10.1b | Waiting List Patient Characteristics at End of Year Intestine Waiting List Inactive Waitlist Patients, 1999 to 2008 | (42 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 10.2 | Time to Transplant, 1999 to 2008 New Intestine Waiting List Registrations | (80 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 10.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Intestine Waiting List | (60 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 10.4 | Transplant Recipient Characteristics, 1999 to 2008 Intestine Recipients | (44 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 10.5 | Incidence of Transplant, 1999 to 2008 Intestine Transplants per 1 Million Population | (47 k) |
| 10.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Intestine Transplants | (32 k) |
| 10.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Intestine Transplants | (30 k) |
| 10.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Intestine Transplants | (29 k) |
| 10.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Intestine Transplants | (28 k) |
| 10.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Intestine Transplants | (29 k) |
| 10.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Intestine Transplants | (30 k) |
| 10.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Intestine Transplants | (32 k) |
| 10.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Intestine Transplants | (28 k) |
| 10.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Intestine Transplants | (31 k) |
| 10.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Intestine Transplantation | (91 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 10.8 | Adjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (43 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 10.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants | (22 k) |
| 10.10 | Unadjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (48 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 10.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants | (21 k) |
| 10.12 | Adjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (41 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 10.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants | (21 k) |
| 10.14 | Unadjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (47 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 10.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants | (22 k) |
| 10.16 | Prevalence of People Living with a Functioning Transplant at End of Year Intestine Recipients, 1999 to 2007 | (42 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 10.17 | Transplants by State and Transplant Center, 1999 to 2008 Intestine | (43 k) |
Section XI | ||
| 11.1a | Waiting List Patient Characteristics at End of Year Heart Waiting List Active Waitlist Patients, 1999 to 2008 | (44 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Patient Status | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 11.1b | Waiting List Patient Characteristics at End of Year Heart Waiting List Inactive Waitlist Patients, 1999 to 2008 | (44 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 11.2a | Events 7 & 30 Days After Listing 2007 and 2008 Heart Registrations with Initial Status 1A | (19 k) |
| 11.2b | Events 30 Days After Snapshot of Prevalent Waiting List Patients on Heart Waiting List on Jan. 1, 2008 | (33 k) |
| 30 Days After Snapshot | ||
| 60 Days After Snapshot | ||
| 90 Days After Snapshot | ||
| 11.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Heart Waiting List | (75 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| Patient Status | ||
| State of Center | ||
| 11.4 | Transplant Recipient Characteristics, 1999 to 2008 Heart Recipients | (49 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| Procedure Type | ||
| 11.5 | Incidence of Transplant, 1999 to 2008 Heart Transplants per 1 Million Population | (48 k) |
| 11.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Heart Transplants | (32 k) |
| 11.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Heart Transplants | (32 k) |
| 11.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Heart Transplants | (29 k) |
| 11.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Heart Transplants | (29 k) |
| 11.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Heart Transplants | (32 k) |
| 11.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Heart Transplants | (31 k) |
| 11.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Heart Transplants | (33 k) |
| 11.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Heart Transplants | (35 k) |
| 11.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Heart Transplants | (33 k) |
| 11.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Heart Transplantation | (119 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Procedure Type | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 11.8 | Adjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (48 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 11.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants | (21 k) |
| 11.10 | Unadjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (57 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Procedure Type | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 11.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants | (21 k) |
| 11.12 | Adjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (46 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 11.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants | (21 k) |
| 11.14 | Unadjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (57 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Procedure Type | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 11.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants | (21 k) |
| 11.16 | Prevalence of People Living with a Functioning Transplant at End of Year Heart Recipients, 1999 to 2007 | (45 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Patient Status | ||
| Race | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Procedure Type | ||
| 11.17 | Transplants by State and Transplant Center, 1999 to 2008 Heart | (71 k) |
Section XII | ||
| 12.1a | Waiting List Patient Characteristics at End of Year Lung Waiting List Active Waitlist Patients, 1999 to 2008 | (51 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Lung Allocation Score | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Lung Diagnosis Group | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 12.1b | Waiting List Patient Characteristics at End of Year Lung Waiting List Inactive Waitlist Patients, 1999 to 2008 | (56 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Lung Allocation Score | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Lung Diagnosis Group | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 12.2 | Time to Transplant, 1999 to 2008 New Lung Waiting List Registrations | (87 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 12.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Lung Waiting List | (81 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Lung Allocation Score | ||
| Race | ||
| Lung Diagnosis Group | ||
| State of Center | ||
| 12.4 | Transplant Recipient Characteristics, 1999 to 2008 Recipients of Deceased Donor Lungs | (55 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Lung Diagnosis Group | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| Lung Allocation Score | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| Procedure Type | ||
| 12.5 | Incidence of Transplant, 1999 to 2008 Lung Transplants per 1 Million Population | (47 k) |
| 12.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Lung Transplants | (32 k) |
| 12.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Lung Transplants | (32 k) |
| 12.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Lung Transplants | (29 k) |
| 12.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Lung Transplants | (29 k) |
| 12.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Lung Transplants | (32 k) |
| 12.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Lung Transplants | (30 k) |
| 12.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Lung Transplants | (32 k) |
| 12.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Lung Transplants | (46 k) |
| 12.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Lung Transplants | (33 k) |
| 12.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Deceased Donor Lung Transplantation | (126 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Lung Diagnosis Group | ||
| Previous Transplant | ||
| Procedure Type | ||
| Age | ||
| Cold Ischemic Time | ||
| Lung Allocation Score | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 12.8 | Adjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (44 k) |
| Age | ||
| Gender | ||
| Race | ||
| Lung Diagnosis Group | ||
| Diagnosis | ||
| Lung Allocation Score | ||
| State of Center | ||
| 12.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years | (22 k) |
| 12.10 | Unadjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (54 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Lung Diagnosis Group | ||
| Previous Transplant Same Organ | ||
| Procedure Type | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| Lung Allocation Score | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 12.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years | (22 k) |
| 12.12 | Adjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (44 k) |
| Age | ||
| Gender | ||
| Race | ||
| Lung Diagnosis Group | ||
| Diagnosis | ||
| Lung Allocation Score | ||
| State of Center | ||
| 12.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years | (22 k) |
| 12.14 | Unadjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (54 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Lung Diagnosis Group | ||
| Procedure Type | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| Lung Allocation Score | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 12.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years | (22 k) |
| 12.16 | Prevalence of People Living with a Functioning Transplant at End of Year Lung Recipients, 1999 to 2007 | (49 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Type | ||
| Lung Diagnosis Group | ||
| Age | ||
| Diagnosis | ||
| Lung Allocation Score | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Procedure Type | ||
| 12.17 | Transplants by State and Transplant Center, 1999 to 2008 Lung | (55 k) |
Section XIII | ||
| 13.1a | Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1999 to 2008 | (48 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 13.1b | Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Inactive Waitlist Patients, 1999 to 2008 | (48 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 13.2 | Time to Transplant, 1999 to 2008 New Heart-Lung Waiting List Registrations | (78 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 13.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Heart-Lung Waiting List | (72 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 13.4 | Transplant Recipient Characteristics, 1999 to 2008 Heart-Lung Recipients | (43 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 13.5 | Incidence of Transplant, 1999 to 2008 Heart-Lung Transplants per 1 Million Population | (46 k) |
| 13.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Heart-Lung Transplants | (28 k) |
| 13.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Heart-Lung Transplants | (29 k) |
| 13.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung Transplants | (28 k) |
| 13.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung Transplants | (32 k) |
| 13.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Heart-Lung Transplants | (37 k) |
| 13.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung Transplants | (32 k) |
| 13.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Heart-Lung Transplantation | (83 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 13.8 | Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (41 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 13.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.10 | Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (47 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 13.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.12 | Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (41 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 13.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.14 | Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (47 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 13.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.16 | Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1999 to 2007 | (42 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 13.17 | Transplants by State and Transplant Center, 1999 to 2008 Heart-Lung | (57 k) |
Section XIV | ||
| 14.1 | History of Cancer among Deceased Donors, 1999 to 2008 | (29 k) |
| 14.2 | Recipient Recurrence of Pretransplant Malignancies, 1999 to 2008 | (44 k) |
| 14.3 | Recipient De Novo Posttransplant Solid Malignancies, 1999 to 2008 by Transplant Type | (30 k) |
| 14.4 | Recipient De Novo Posttransplant Lymphoproliferative Disorders (PTLD), 1999 to 2008 by Transplant Type | (30 k) |
| 14.5 | History of Cancer among Deceased Kidney Donors 1999 to 2008 | (29 k) |
| 14.6 | De Novo Posttransplant Solid Malignancy, 1999 to 2008 Kidney Recipients | (32 k) |
| 14.7 | History of Cancer among Deceased Liver Donors 1999 to 2008 | (29 k) |
| 14.8 | De Novo Posttransplant Solid Malignancy, 1999 to 2008 Liver Recipients | (32 k) |
| 14.9 | History of Cancer among Deceased Heart Donors 1999 to 2008 | (29 k) |
| 14.10 | De Novo Posttransplant Solid Malignancy, 1999 to 2008 Heart Recipients | (32 k) |
Section XV | ||
| 15.1 | Waiting Time Before Transplant - Excluding Inactive Time, Censored at WL Removal New Waiting List Registrations, 1999 to 2008 | (42 k) |
| 15.2 | Time to Transplant, 1999 to 2008 New Liver Waiting List Registrations | (115 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Patient Status | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 15.3 | Time to Transplant, 1999 to 2008 New Heart Waiting List Registrations | (103 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Patient Status | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 15.4a | Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor Kidneys | (47 k) |
| Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor Kidneys | ||
| Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Deceased Donor Kidneys | ||
| Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Deceased Donor Kidneys | ||
| 15.4b | Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor Kidneys | (46 k) |
| Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor Kidneys | ||
| Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Living Donor Kidneys | ||
| Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Living Donor Kidneys | ||
| 15.5a | Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor Livers | (46 k) |
| Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Deceased Donor Livers | ||
| Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Deceased Donor Livers | ||
| Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Deceased Donor Livers | ||
| 15.5b | Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor Livers | (45 k) |
| Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Living Donor Livers | ||
| Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Living Donor Livers | ||
| Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Living Donor Livers | ||
| 15.6 | Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Heart Transplants | (45 k) |
| Steroid Avoidance Rate at Discharge, 1999 to 2008 Recipients of Heart Transplants | ||
| Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2007 Recipients of Heart Transplants | ||
| Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2006 Recipients of Heart Transplants | ||
| 15.7 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Kidney Transplants | (31 k) |
| 15.8 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 15.9 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants | (30 k) |
| 15.10 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Kidney-Pancreas Transplants | (30 k) |
| 15.11 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Liver Transplants | (31 k) |
| 15.12 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Intestine Transplants | (30 k) |
| 15.13 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Heart Transplants | (31 k) |
| 15.14 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Lung Transplants | (31 k) |
| 15.15 | Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2006 Recipients with Heart-Lung Transplants | (30 k) |
